ReviewJournal of cardiovascular echography
Beyond Echocardiography: The Evolving Role of Imaging in Left Atrial Appendage Closure in the Modern Era.
Review in Journal of cardiovascular echography. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left atrial appendage closure (LAAC) has emerged as a crucial alternative for stroke prevention in patients with atrial fibrillation ineligible for long-term anticoagulation. While echocardiography, particularly transesophageal echocardiography (TEE), remains fundamental for procedural planning and guidance, the integration of multimodal imaging is increasingly shaping contemporary practice. This review explores the evolving landscape of imaging for LAAC, highlighting their complementary roles, technological advancements, and future directions in optimizing procedural outcomes. TEE is the standard imaging modality for LAAC, providing comprehensive anatomical and functional assessment across all procedural phases. However, advanced cardiac imaging techniques, including cardiac computed tomography (CCT) and cardiac magnetic resonance (CMR), are gaining prominence. CCT offers detailed anatomical characterization of the left atrial appendage (LAA) and surrounding structures, aiding in device sizing and excluding thrombus. CMR provides superior tissue characterization and can be an alternative when TEE is not feasible. Intracardiac echocardiography may be a valid alternative to TEE ti guide device deployment and assessment. This review critically evaluates the strengths and limitations of each imaging modality in the LAAC procedure, from pre-procedural planning and patient selection to intraprocedural guidance and post-procedural assessment for complications like device leaks and device-related thrombosis. The evolving role of three-dimensional imaging and potential future applications, such as artificial intelligence-assisted image analysis, are also considered. Understanding the complementary roles of these imaging modalities is crucial for optimizing patient care in the modern era of LAAC. LAAC has emerged as a crucial alternative for stroke prevention in patients with atrial fibrillation who are ineligible for long-term anticoagulation. While echocardiography remains the cornerstone of procedural planning and guidance, the expanding role of multimodal imaging is reshaping current practice. Advanced cardiac imaging techniques, including CCT and CMR, are increasingly integrated into patient selection, device sizing, and post-procedural assessment, enhancing safety and efficacy. This review explores the evolving landscape of imaging modalities in LAAC, highlighting their complementary roles, recent technological advances, and future directions in optimizing procedural outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.